TrialThe oncologist2019

A Randomized, Double-Blinded, Phase II Trial of Carboplatin and Pemetrexed with or without Apatorsen (OGX-427) in Patients with Previously Untreated Stage IV Non-Squamous-Non-Small-Cell Lung Cancer: The SPRUCE Trial.

David R Spigel et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.